Search

Alicia L. Otton

Examiner (ID: 9618)

Most Active Art Unit
1626
Art Unit(s)
1626, 1699, 4121
Total Applications
1585
Issued Applications
975
Pending Applications
99
Abandoned Applications
544

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18233181 [patent_doc_number] => 11597729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-03-07 [patent_title] => Tropomyosin receptor kinase inhibitor, preparation method therefor and use thereof [patent_app_type] => utility [patent_app_number] => 17/044791 [patent_app_country] => US [patent_app_date] => 2019-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10135 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044791 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/044791
Tropomyosin receptor kinase inhibitor, preparation method therefor and use thereof Jun 5, 2019 Issued
Array ( [id] => 16794106 [patent_doc_number] => 20210123923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => METHODS OF MONITORING, TREATING, AND PREVENTING RENAL INFLAMMATION ASSOCIATED WITH NEPHROTOXICITY [patent_app_type] => utility [patent_app_number] => 15/734581 [patent_app_country] => US [patent_app_date] => 2019-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15578 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734581 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/734581
METHODS OF MONITORING, TREATING, AND PREVENTING RENAL INFLAMMATION ASSOCIATED WITH NEPHROTOXICITY Jun 5, 2019 Abandoned
Array ( [id] => 16892050 [patent_doc_number] => 11033577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-15 [patent_title] => Polymer conjugate of hexa-coordinated platinum complex [patent_app_type] => utility [patent_app_number] => 16/431811 [patent_app_country] => US [patent_app_date] => 2019-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23823 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 567 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16431811 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/431811
Polymer conjugate of hexa-coordinated platinum complex Jun 4, 2019 Issued
Array ( [id] => 16892050 [patent_doc_number] => 11033577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-15 [patent_title] => Polymer conjugate of hexa-coordinated platinum complex [patent_app_type] => utility [patent_app_number] => 16/431811 [patent_app_country] => US [patent_app_date] => 2019-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23823 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 567 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16431811 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/431811
Polymer conjugate of hexa-coordinated platinum complex Jun 4, 2019 Issued
Array ( [id] => 16743237 [patent_doc_number] => 10968211 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-06 [patent_title] => Hepatitis B core protein modulators [patent_app_type] => utility [patent_app_number] => 16/426727 [patent_app_country] => US [patent_app_date] => 2019-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 151487 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 558 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16426727 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/426727
Hepatitis B core protein modulators May 29, 2019 Issued
Array ( [id] => 17156065 [patent_doc_number] => 20210317116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => N-1 BRANCHED CYCLOALKYL SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS, COMPOSITIONS, AND METHODS [patent_app_type] => utility [patent_app_number] => 17/250073 [patent_app_country] => US [patent_app_date] => 2019-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17008 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17250073 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/250073
N-1 branched cycloalkyl substituted imidazo[4,5-c]quinoline compounds, compositions, and methods May 22, 2019 Issued
Array ( [id] => 14990973 [patent_doc_number] => 20190314444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => ETBR ANTAGONIST COMPOUNDS, COMPOSITIONS, AND USES [patent_app_type] => utility [patent_app_number] => 16/419931 [patent_app_country] => US [patent_app_date] => 2019-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32445 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16419931 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/419931
ETBR ANTAGONIST COMPOUNDS, COMPOSITIONS, AND USES May 21, 2019 Abandoned
Array ( [id] => 17243407 [patent_doc_number] => 20210363150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-25 [patent_title] => ARYL TRIAZOLE CAGES [patent_app_type] => utility [patent_app_number] => 16/965283 [patent_app_country] => US [patent_app_date] => 2019-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17767 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965283 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/965283
Aryl triazole cages May 21, 2019 Issued
Array ( [id] => 14806097 [patent_doc_number] => 20190269658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-05 [patent_title] => PHARMACEUTICAL COMPOSITIONS DIRECTLY TARGETING FKBP52 FOR THE TREATMENT OF PROSTATE CANCER AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 16/415141 [patent_app_country] => US [patent_app_date] => 2019-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7539 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16415141 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/415141
Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same May 16, 2019 Issued
Array ( [id] => 14774863 [patent_doc_number] => 20190262329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-29 [patent_title] => MUSCARINIC ANTAGONISTS AND COMBINATIONS THEREOF FOR THE TREATMENT OF AIRWAY DISEASE IN HORSES [patent_app_type] => utility [patent_app_number] => 16/406918 [patent_app_country] => US [patent_app_date] => 2019-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8383 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16406918 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/406918
Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses May 7, 2019 Issued
Array ( [id] => 16222710 [patent_doc_number] => 20200247826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-06 [patent_title] => COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME, BACKLIGHT UNIT, AND DISPLAY DEVICE [patent_app_type] => utility [patent_app_number] => 16/652250 [patent_app_country] => US [patent_app_date] => 2019-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7141 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16652250 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/652250
Compound and color conversion film comprising same, backlight unit, and display device Apr 29, 2019 Issued
Array ( [id] => 14723123 [patent_doc_number] => 20190252625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => ORGANIC LIGHT-EMITTING DEVICE, AND LIGHT-EMITTING MATERIAL AND COMPOUND USED THEREFOR [patent_app_type] => utility [patent_app_number] => 16/394055 [patent_app_country] => US [patent_app_date] => 2019-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31837 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16394055 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/394055
ORGANIC LIGHT-EMITTING DEVICE, AND LIGHT-EMITTING MATERIAL AND COMPOUND USED THEREFOR Apr 24, 2019 Abandoned
Array ( [id] => 16657343 [patent_doc_number] => 20210053979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => MACROCYCLIC TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS [patent_app_type] => utility [patent_app_number] => 17/043886 [patent_app_country] => US [patent_app_date] => 2019-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24111 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 289 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17043886 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/043886
Macrocyclic toll-like receptor 7 (TLR7) agonists Apr 22, 2019 Issued
Array ( [id] => 14684921 [patent_doc_number] => 20190241575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => TYK2 INHIBITORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/382734 [patent_app_country] => US [patent_app_date] => 2019-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 294834 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382734 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/382734
TYK2 inhibitors and uses thereof Apr 11, 2019 Issued
Array ( [id] => 14684925 [patent_doc_number] => 20190241577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => TYK2 INHIBITORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/382907 [patent_app_country] => US [patent_app_date] => 2019-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 297022 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382907 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/382907
TYK2 inhibitors and uses thereof Apr 11, 2019 Issued
Array ( [id] => 14746691 [patent_doc_number] => 20190256519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-22 [patent_title] => TYK2 INHIBITORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/382680 [patent_app_country] => US [patent_app_date] => 2019-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 296744 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382680 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/382680
TYK2 inhibitors and uses thereof Apr 11, 2019 Issued
Array ( [id] => 15512661 [patent_doc_number] => 10562906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-18 [patent_title] => TYK2 inhibitors and uses thereof [patent_app_type] => utility [patent_app_number] => 16/382824 [patent_app_country] => US [patent_app_date] => 2019-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 298107 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382824 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/382824
TYK2 inhibitors and uses thereof Apr 11, 2019 Issued
Array ( [id] => 15512663 [patent_doc_number] => 10562907 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-18 [patent_title] => TYK2 inhibitors and uses thereof [patent_app_type] => utility [patent_app_number] => 16/382869 [patent_app_country] => US [patent_app_date] => 2019-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 298272 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382869 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/382869
TYK2 inhibitors and uses thereof Apr 11, 2019 Issued
Array ( [id] => 15649555 [patent_doc_number] => 20200087307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-19 [patent_title] => BICYCLIC COMPOUNDS AS ATX INHIBITORS [patent_app_type] => utility [patent_app_number] => 16/380909 [patent_app_country] => US [patent_app_date] => 2019-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13368 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16380909 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/380909
Bicyclic compounds as ATX inhibitors Apr 9, 2019 Issued
Array ( [id] => 17822618 [patent_doc_number] => 11427554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-30 [patent_title] => Lactone compound and novel ether compound [patent_app_type] => utility [patent_app_number] => 17/044080 [patent_app_country] => US [patent_app_date] => 2019-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23156 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044080 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/044080
Lactone compound and novel ether compound Apr 7, 2019 Issued
Menu